See also this year's filing and all EDGAR filings for this company.
PDF Report 0001697805_2018_Xynomic_Pharmaceuticals_Holdings_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001697805, Xynomic Pharmaceuticals Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 299,618 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 62,208,330 |
| 4 | LiabilitiesCurrent | 80,473 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 365,215 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 323,955 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 62,507,948 |
| 1 | Liabilities | 80,473 |
| 2 | Expenses | 365,215 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 62,427,475 |
| 5 | NetIncome | -41,260 |
| 6 | ComprehensiveNetIncome | -41,260 |
| 7 | BaseVar | 31,638,796 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.35 |
| 9 | EconomicCapitalRatio | 4.66 |
Edgar->Model Mapping
Feature Distribution
